Research Article
Characteristics of Hypoglycemic Diabetic Patients Visiting the Emergency Room
Table 2
Baseline comparisons between frequencies of visit.
| | HYPO_S group | HYPO_M group | value |
| | Number, (%) | 744 (88%) | 99 (12%) | | | Age (year) | | | 0.365 | | Female, (%) | 347 (46.6) | 43 (43.4) | 0.548 | | BMI (kg/m2) | | | 0.346 | | Alcohol (binge), (%) | 73 (9.8) | 15 (15.2) | 0.103 | | Type 1 DM, (%) | 16 (2.2) | 3 (3.0) | 0.480 | | DM duration (year) | 8.0 (4-20) | 10.0 (2-20) | 0.573 | | Medication, (%) | | | | | Insulin | 358 (48.1) | 47 (47.5) | 0.904 | | Sulfonylurea | 251 (33.7) | 39 (39.4) | 0.266 | | Meglitinide | 40 (5.4) | 4 (4.0) | 0.575 | | Metformin | 149 (20.0) | 16 (16.2) | 0.363 | | DPP4i | 128 (17.2) | 11 (11.1) | 0.125 | | SGLT2i | 2 (0.3) | 0 (0.0) | >0.999 | | Thiazolidinediones | 15 (2.0) | 5 (5.1) | 0.074 | | α-Glucosidase inhibitors | 7 (0.9) | 1 (1.0) | >0.999 | | HbA1c (%) | | | 0.667 | | BUN (mg/dL) | 24 (16-37) | 23 (16-33) | 0.525 | | Cr (mg/dL) | 1.14 (0.80-2.23) | 1.22 (0.88-1.92) | 0.505 | | eGFR (mL/min/1.73m2) | 55 (27-81) | 51 (32-75) | 0.763 | | Total protein (g/dL) | | | 0.255 | | Albumin (g/dL) | | | 0.186 | | Sodium (mmol/L) | | | 0.499 | | Potassium (mmol/L) | | | 0.289 | | Cl (mmol/L) | | | 0.058 | | Total bilirubin (mg/dL) | 0.4 (0.31-0.63) | 0.4 (0.28-0.54) | 0.020 | | AST (IU/L) | 27 (21-39) | 25 (20-30) | 0.018 | | ALT (IU/L) | 19 (14-29) | 18 (13-26) | 0.092 | | CPK, | 88 (52-165) | 89 (50-179) | 0.905 | | LDH, | 497 (411-622) | 457 (391-553) | 0.006 | | Amylase (μL/dL) | 98 (69-135) | 106 (73-144) | 0.242 | | Lipase (U/L) | 23 (12-47) | 28 (10-52) | 0.808 | | PT_INR (INR) | | | <0.001 | | hsCRP (mg/dL) | 0.24 (0.06-1.63) | 0.15 (0.04-1.03) | 0.062 | | Platelet count (K/μL) | | | 0.008 | | WBC count, | 8.0 (6-11) | 8.0 (6-11) | 0.502 | | ANC, | | | 0.169 | | RBC count, | 3.72 (3.32-4.23) | 3.85 (3.50-4.10) | 0.215 | | Hemoglobin (g/dL) | | | 0.224 | | Hematocrit (M/μL) | | | 0.188 | | ALP (IU/L) | 73 (55-123) | 60 (45-89) | 0.059 | | Gamma-GTP (IU/L) | 31 (17-110) | 26 (17-37) | 0.086 | | TC (mg/dL) | | | 0.519 | | TG (mg/dL) | 73 (53-98) | 86 (56-136) | 0.557 | | HDL (mg/dL) | | | 0.180 | | LDL (mg/dL) | | | 0.776 | | Osmolality (mOsm/kg) | | | 0.259 | | Comorbidity, (%) | | | | | Ischemic heart disease | 194 (26.1) | 25 (25.3) | 0.861 | | Cerebrovascular disease | 178 (23.9) | 24 (24.2) | 0.945 | | Hypertensive disease | 162 (21.8) | 23 (23.2) | 0.742 | | Aneurysm | 136 (18.3) | 23 (23.2) | 0.237 | | Heart failure | 53 (7.1) | 4 (4.0) | 0.251 | | Renal failure | 15 (2.0) | 2 (2.0) | >0.999 | | Sudden cardiac death | 1 (0.1) | 0 (0.0) | >0.999 | | Cancer | 124 (16.7) | 6 (6.1) | 0.006 |
|
|
BMI: body mass index; BUN: blood urea nitrogen; DM: diabetes mellitus; DPP4i: dipeptidyl peptidase-4 inhibitor; SGLT2i: sodium-glucose cotransporter 2 inhibitors; GFR: glomerular filtration rate.
|
